GSK Fights Pfizer's Bid To Nix COVID-19 Vaccine Patents
GlaxoSmithKline has denied Pfizer and BioNTech's claims that its patents protecting key processes in the manufacture of COVID-19 vaccines should be nixed, arguing that they were infringing its IP through the...To view the full article, register now.
Already a subscriber? Click here to view full article